1. Home
  2. GRBK vs KNSA Comparison

GRBK vs KNSA Comparison

Compare GRBK & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Brick Partners Inc.

GRBK

Green Brick Partners Inc.

HOLD

Current Price

$62.50

Market Cap

2.9B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$41.16

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRBK
KNSA
Founded
N/A
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
GRBK
KNSA
Price
$62.50
$41.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$71.00
$51.33
AVG Volume (30 Days)
248.1K
378.6K
Earning Date
10-29-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.63
0.47
Revenue
$2,113,173,000.00
$597,973,000.00
Revenue This Year
N/A
$62.63
Revenue Next Year
$0.78
$29.93
P/E Ratio
$8.27
$87.80
Revenue Growth
6.62
55.68
52 Week Low
$50.57
$17.82
52 Week High
$77.93
$44.42

Technical Indicators

Market Signals
Indicator
GRBK
KNSA
Relative Strength Index (RSI) 37.92 48.28
Support Level $62.52 $40.52
Resistance Level $64.10 $42.15
Average True Range (ATR) 1.22 1.23
MACD -0.28 -0.19
Stochastic Oscillator 0.87 21.15

Price Performance

Historical Comparison
GRBK
KNSA

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: